Press Releases

• Cyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K

  31 May, 2023 14:00 CEST

• Bulletin from the annual general meeting in Cyxone AB on 30 May 2023

  30 May, 2023 11:00 CEST
  Regulatory

• Interim Report 1 January to 31 March 2023

  12 May, 2023 08:22 CEST
  Regulatory

• Cyxone receives patent approval from the US for the salt forms of the compound rabeximod

  9 May, 2023 13:45 CEST
  Regulatory

• Annual Report from Cyxone AB for the period 1 January 2022 to 31 December 2022

  27 Apr, 2023 13:03 CEST
  Regulatory